1. P186 Facilitators to recruiting COPD patients to an adherence intervention trial. (11th November 2022) Authors: Dickens, AP; Halpin, DMG; Carter, V; Skinner, D; Beeh, K; Chalmers, J; Clark, A; Hannan, N; Kaplan, A; Kostikas, K; Pinnock, H; Roche, N; Usmani, O; van Boven, JFM; Mastoridis, P; Mezzi, K; Davis, S; Vijaykumar, E; Price, D Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P233 Efficacy and safety of once-daily glycopyrronium compared with blinded tiotropium in patients with COPD: the GLOW5 study. (14th November 2013) Authors: Chapman, KR; Beeh, K; Bateman, ED; Beier, J; D'Urzo, AD; Nutbrown, R; Chen, H; Henley, M; Overend, T; D'Andrea, P Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P254 NVA237 once daily improves exercise endurance in patients with COPD from the first dose: the GLOW3 trial. (2nd December 2011) Authors: Singh, D; Beeh, K; Drollmann, A; Di Scala, L; Smith, R Journal: Thorax Issue: Volume 66(2011)Supplement 4 Page Start: A170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S117 Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial. (11th November 2022) Authors: Dickens, AP; Halpin, DMG; Carter, V; Skinner, D; Beeh, K; Chalmers, J; Clark, A; Hannan, N; Kaplan, A; Kostikas, K; Pinnock, H; Roche, N; Usmani, O; van Boven, JFM; Mastoridis, P; Mezzi, K; Davis, S; Vijaykumar, E; Price, D Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗